FrancophonIA/ELRC3.0 huggingface dataset:
English: In general, the adverse events in paediatric patients with juvenile idiopathic arthritis were similar in frequency and type to those seen in adult patients.
Estonian: Üldiselt oli juveniilse idiopaatilise artriidiga lastel esinevate kõrvaltoimete sagedus ja tüüp sarnane täiskasvanutega.
English: Live vaccines should not be given concurrently with Erelzi.
Estonian: Samaaegselt Erelziga ei tohi elusvaktsiine manustada.
English: Some have occurred within a few weeks after initiating treatment with etanercept in patients who have underlying conditions (e.g., diabetes, congestive heart failure, history of active or chronic infections) in addition to their rheumatoid arthritis (see section 4.4).
Estonian: Reumatoidartriidiga patsientidel, kellel esines kaasuv haigus (nt diabeet, südame paispuudulikkus, aktiivne või krooniline infektsioon anamneesis), on mõnedel juhtudel infektsioon tekkinud mõne nädala jooksul pärast etanertseptravi alustamist (vt lõik 4.4).
English: Erelzi is only available as 25 mg pre-filled syringe and 50 mg pre-filled syringe and pre-filled pen.
Estonian: Erelzi on saadaval ainult 25 mg süstlis ja 50 mg süstlis ning pen-süstlis.
English: Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis including ankylosing spondylitis The usual dose is 25 mg given twice a week or 50 mg once a week as an injection under the skin.
Estonian: Kasutamine täiskasvanud patsientidel (18-aastased ja vanemad) Reumatoidartriit, psoriaatiline artriit ja aksiaalne spondüloartriit, sh anküloseeriv spondüliit Tavaline annus on 25 mg kaks korda nädalas või 50 mg üks kord nädalas nahaaluse süstena.
English: Talk to your doctor before taking Erelzi.
Estonian: Enne Erelzi võtmist pidage nõu oma arstiga.
English: The solution is clear or slightly opalescent, colourless to slightly yellowish.
Estonian: Lahus on selge või kergelt sillerdav, värvitu kuni kergelt kollakas.
English: Adult patients treated with etanercept and anakinra were observed to have a higher rate of serious infection when compared with patients treated with either etanercept or anakinra alone (historical data).
Estonian: Täiskasvanud patsientidel, keda on samaaegselt ravitud etanertsepti ja anakinraga, on ilmnenud suurem tõsiste infektsioonide esinemissagedus, võrreldes mõlema preparaadi eraldi manustamisega (varasemad andmed).
English: Re-introduction of treatment with etanercept after discontinuation of up to 24 months resulted in the same magnitudes of responses as patients who received etanercept without interruption of therapy based on results of open-label studies.
Estonian: Avatud uuringute andmetel avaldas ravim etanertseptravi taasalustamisel pärast selle ärajätmist kuni 24 kuu jooksul sama tugevusega toimet kui neil patsientidel, kellel etanertseptravi ei katkestatud.
English: One hundred and twenty-nine (129) new malignancies of various types were observed in 4,114 rheumatoid arthritis patients treated in clinical trials with etanercept for up to approximately 6 years, including 231 patients treated with etanercept in combination with methotrexate in a 2-year active-controlled study.
Estonian: Kliinilistes uuringutes sai etanertsepti 4114 reumatoidartriidiga patsienti kuni ligikaudu 6 aastat, seejuures 231 patsienti said 2 aastases aktiivse kontrolliga uuringus etanertsepti ja metotreksaadi kombinatsioonravi.
English: • Once removed, throw away the cap. Do not try to re-attach the cap.
Estonian: • Pärast eemaldamist, visake kork ära.
English: Congestive heart failure (Cardiac failure congestive) Physicians should use caution when using Erelzi in patients who have congestive heart failure (CHF).
Estonian: Südame paispuudulikkus (krooniline südamepuudulikkus) Südame paispuudulikkusega patsientidele Erelzi määramisel peab olema ettevaatlik.
English: In this configuration the needle guard is ACTIVATEDDO NOT USE the pre-filled syringe
Estonian: Sellisel kujul on nõelakaitse AKTIVEERITUD: ÄRGE KASUTAGE süstlit.
English: Thus, the combined use of Erelzi and anakinra is not recommended (see sections 4.5 and 4.8).
Estonian: Kuna see kombinatsioon ei ole üksikkomponentidega võrreldes näidanud suuremat kliinilist efektiivsust, ei soovitata Erelzit ja anakinrat koos kasutada (vt lõigud 4.5 ja 4.8).
English: Citric acid anhydrous Sodium citrate dihydrate Sodium chloride
Estonian: Sidrunhape, veevaba Naatriumtsitraatdihüdraat naatriumkloriid
English: In another active-controlled, double-blind, randomised study, clinical efficacy, safety, and radiographic progression in RA patients treated with etanercept alone (25 mg twice weekly), methotrexate alone (7.5 to 20 mg weekly, median dose 20 mg), and the combination of etanercept and methotrexate initiated concurrently were compared in 682 adult patients with active rheumatoid arthritis of 6 months to 20 years duration (median 5 years) who had a less than satisfactory response to at least 1 disease-modifying antirheumatic drug (DMARD) other than methotrexate.
Estonian: Ühes teises aktiivse kontrolliga, topeltpimedas, randomiseeritud uuringus võrreldi reumatoidartriidiga patsientidel ainult etanertsepti (25 mg 2 korda nädalas), ainult metotreksaadi (7,5…20 mg nädalas, annuse mediaan 20 mg) ning etanertsepti ja metotreksaadi kombinatsioonravi kliinilist efektiivsust, ohutust ja radiograafilist progresseerumist.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS TEXT FOR TRAY BACK - 25 MG PRE-FILLED SYRINGE
Estonian: MINIMAALSED ANDMED, MIS PEAVAD OLEMA BLISTER- VÕI RIBAPAKENDIL ALUSE PÕHJA TEKST - 25 MG SÜSTEL
English: A 10 mg vial strength may be more appropriate for administration to children with JIA below the weight of 25 kg.
Estonian: Alla 25 kg kaaluvatele juveniilse idiopaatilise artriidiga lastele võib sobida paremini 10 mg viaal.
English: Each pre-filled syringe contains 25 mg of etanercept or 50 mg of etanercept.
Estonian: Iga süstel sisaldab 25 mg etanertsepti või 50 mg etanertsepti.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS TEXT FOR TRAY BACK - 50 MG PRE-FILLED SYRINGE
Estonian: MINIMAALSED ANDMED, MIS PEAVAD OLEMA BLISTER- VÕI RIBAPAKENDIL ALUSE PÕHJA TEKST - 50 MG SÜSTEL
English: It is recommended that the conduct of these tests should be recorded in the Patient's Alert Card. Prescribers are reminded of the risk of false negative tuberculin skin test results, especially in patients who are severely ill or immunocompromised.
Estonian: Ravimi ordineerija peab võtma arvesse tuberkuliini nahatesti valenegatiivsete tulemuste võimalust, eriti raskesti haigetel või nõrgenenud immuunsüsteemiga patsientidel.
English: EU/1/17/1195/012 12 pre-filled SensoReady pens
Estonian: MÜÜGILOA NUMBER (NUMBRID) EU/1/17/1195/012 12 SensoReady pen-süstlit 13.
English: By looking through the viewing window, the solution should be clear to slightly opalescent, colourless to slightly yellowish and may contain small translucent or white particles of protein.
Estonian: Läbi süstli akna vaadates peab lahus olema läbipaistev kuni kergelt sillerdav, värvitu kuni kergelt kollakas ning võib sisaldada väikseid poolläbipaistvaid või valgeid valguosakesi.
English: The injection site is the place on the body where you are going to use the pre-filled syringe.
Estonian: Süstekoht on piirkond kehal, kuhu süstitakse.
English: After taking a pre-filled pen from the refrigerator, wait approximately 15-30 minutes to allow the Erelzi solution in the pen to reach room temperature.
Estonian: Pärast pen-süstli võtmist külmikust oodake ligikaudu 15...30 minutit, kuni Erelzi lahus pen-süstlis saavutab toatemperatuuri.
English: The other ingredients are citric acid anhydrous, sodium citrate dihydrate, sodium chloride, sucrose, L-lysine hydrochloride, sodium hydroxide, hydrochloric acid and water for injections.
Estonian: Teised abiained on sidrunhape, veevaba; naatriumtsitraatdihüdraat; naatriumkloriid; sukroos; L-lüsiinvesinikkloriid; naatriumhüdroksiid; vesinikkloriidhape ja süstevesi.
English: In the controlled clinical trials that allowed concomitant treatment with etanercept and methotrexate, the frequency (incidence proportion) of autoimmune hepatitis was 0.24% (frequency uncommon).
Estonian: Kontrollitud kliinilistes uuringutes, kus oli lubatud etanertsepti ja metotreksaadi kooskasutamine, oli autoimmuunse hepatiidi esinemissagedus (esinemise osakaal) 0,24% (sagedus: aeg-ajalt).
English: Erelzi contains sodium
Estonian: Erelzi sisaldab naatriumi
English: In the controlled clinical trials that allowed concomitant treatment with etanercept and methotrexate, the frequency (incidence proportion) of interstitial lung disease was 0.47% (frequency uncommon).
Estonian: Kontrollitud kliinilistes uuringutes, kus oli lubatud etanertsepti ja metotreksaadi kooskasutamine, oli interstitsiaalse kopsuhaiguse esinemissagedus (esinemise osakaal) 0,47% (sagedus: aeg-ajalt).
English: Comprehensive instructions for administration are given in the package leaflet, section 7, "Instructions for use of the Erelzi pre-filled syringe” or “Instructions for use of the Erelzi SensoReady pen”.
Estonian: Üksikasjalikud manustamisjuhised on toodud pakendi infolehe punktis 7 „Erelzi süstli kasutusjuhend“ või „Erelzi SensoReady pen-süstli kasutusjuhend ”.
English: A 25 mg strength of Erelzi is available for doses of 25 mg.
Estonian: Erelzi 25 mg annuste manustamiseks on saadaval Erelzi 25 mg annused.
English: 2 pre-filled SensoReady pens
Estonian: 2 SensoReady pen-süstlit
English: Etanercept 25 mg was significantly superior to methotrexate for erosion scores at both 12 and 24 months.
Estonian: Erosioonide skoori põhjal oli ravi 12. ja 24. kuul 25 mg etanertseptiga märgatavalt tõhusam kui metotreksaadiga.
English: A careful risk/benefit evaluation, including a neurologic assessment, is recommended when prescribing Erelzi to patients with pre-existing or recent onset of demyelinating disease, or to those who are considered to have an increased risk of developing demyelinating disease.
Estonian: Erelzi määramisel haigetele, kelle anamneesis on olemasolev või hiljutine demüeliniseeriv haigus või kellel esineb suurenenud risk demüeliniseeriva haiguse tekkeks, tuleb eelnevalt hoolikalt hinnata ravi riski ja kasu suhet, sealhulgas teostada neuroloogiline uuring.
English: EU/1/17/1195/013 8 pre-filled syringes EU/1/17/1195/004 12 pre-filled syringes EU/1/17/1195/014 24 pre-filled syringes
Estonian: EU/1/17/1195/013 8 süstlit EU/1/17/1195/004 12 süstlit EU/1/17/1195/014 24 süstlit
English: No study has been performed in patients with psoriatic arthritis using the 50 mg once-weekly dosing regimen.
Estonian: Psoriaatilise artriidiga patsientidel ei ole tehtud uuringuid annustamisskeemiga 50 mg üks kord nädalas.
English: Erelzi should be used with caution in patients with a history of hepatitis C.
Estonian: Patsientidel, kellel on esinenud C-hepatiiti, tuleb Erelzit kasutada ettevaatusega.
English: Melanoma and non-melanoma skin cancer (NMSC) have been reported in patients treated with TNF-antagonists, including etanercept.
Estonian: TNF-antagonistide, sealhulgas etanertseptiga ravitud patsientidel on esinenud melanoomi ja mittemelanoomset nahavähki.
English: Multipack: 12 (3 packs of 4) pre-filled syringes with a needle guard.
Estonian: Mitmikpakend: 12 (3 pakendit, igaühes 4 süstlit) süstlit nõelakaitsmega
English: The efficacy of etanercept in patients with non-radiographic axial spondyloarthritis (nr-AxSpa) was assessed in a randomised, 12-week double-blind, placebo-controlled study.
Estonian: Etanertsepti efektiivsust radiograafilise leiuta aksiaalse spondüloartriidiga patsientide ravis hinnati randomiseeritud, 12-nädalases topeltpimedas, platseebokontrolliga uuringus.
English: In a fourth study, the safety and efficacy of 50 mg etanercept (two 25 mg SC injections) administered once weekly vs. 25 mg etanercept administered twice weekly were evaluated in a double-blind, placebo-controlled study of 356 patients with active ankylosing spondylitis.
Estonian: Neljandas, topeltpimedas, platseebokontrolliga uuringus 356-l aktiivse anküloseeriva spondüliidiga patsiendil võrreldi võrreldi üks kord nädalas manustatud 50 mg etanertsepti (kaks 25 mg sc süstet) ja kaks korda nädalas manustatud 25 mg etanertsepti ohutust ja efektiivsust.
English: The other ingredients are: citric acid anhydrous, sodium citrate dihydrate, sodium chloride, sucrose, L-lysine hydrochloride, sodium hydroxide, hydrochloric acid and water for injections.
Estonian: Abiaineteks on: sidrunhape, veevaba; naatriumtsitraatdihüdraat; naatriumkloriid; sukroos; L-lüsiinvesinikkloriid; naatriumhüdroksiid; vesinikkloriidhape ja süstevesi.
English: Erelzi 25 mg solution for injection in pre-filled syringe EU/1/17/1195/001
Estonian: Erelzi 25 mg süstelahus süstlis EU/1/17/1195/001
English: Correct
Estonian: KÕLBLIKKUSAEG
English: Paediatric plaque psoriasis outcomes at 12 weeks Etanercept 0.8 mg/kg Once Weekly (N = 106)
Estonian: Etanertsept 0,8 mg/kg üks kord nädalas (N = 106)
English: In controlled clinical trials of etanercept across all indications, the frequency (incidence proportion) of autoimmune hepatitis in patients receiving etanercept without concomitant methotrexate was 0.02% (frequency rare).
Estonian: Etanertsepti kontrollitud kliinilistes uuringutes oli autoimmuunse hepatiidi esinemissagedus (esinemise osakaal) etanertsepti saavatel patsientidel ilma kaasneva metotreksaadita kõigil näidustustel 0,02% (sagedus: harv).
English: All subdomains of the HAQ were improved in patients treated with etanercept compared to controls at 3 and 6 months.
Estonian: Paranemine ilmnes kõigis küsimustiku alalõikudes 3 ja 6 kuu vältel etanertseptiga ravitud patsientidel, võrreldes platseebot saanud patsientidega.
English: Hypoglycaemia in patients treated for diabetes
Estonian: Hematoloogilise düskraasia anamneesiga patsientide ravimisel
English: Treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy.
Estonian: Raske aktiivse anküloseeriva spondüliidi ravi täiskasvanutel, kui tavapärane ravi ei olnud piisav.
English: Patients aged 4 to 17 years with moderately to severely active polyarticular-course juvenile idiopathic arthritis refractory to, or intolerant of, methotrexate were enrolled; patients remained on a stable dose of a single non-steroidal anti-inflammatory drug and/or prednisone (< 0.2 mg/kg/day or 10 mg maximum).
Estonian: Patsientidele manustati stabiilse annusena ühte mittesteroidset põletikuvastast preparaati ja/või prednisooni (< 0,2 mg/kg ööpäevas või maksimaalselt 10 mg).
English: Keep the pre-filled syringes and the pre-filled pens in the outer carton in order to protect from light.
Estonian: Hoida süstlid ja pen-süstlid välispakendis valguse eest kaitstult.
English: All patients and parents/caregivers should be advised that if the patient develops signs and symptoms suggestive of blood dyscrasias or infections (e.g., persistent fever, sore throat, bruising, bleeding, paleness) whilst on Erelzi, they should seek immediate medical advice.
Estonian: Kõiki patsiente ja nende vanemaid/hooldajaid tuleb informeerida, et nad peavad arstiga ühendust võtma kohe, kui Erelzi-ravi ajal tekivad patsientidel vereloomehäirele või infektsioonile viitavad sümptomid (nt püsiv palavik, kurguvalu, verevalumid, veritsemine, kahvatus).
English: Among patients with ankylosing spondylitis who received etanercept, the clinical responses were apparent at the time of the first visit (2 weeks) and were maintained through 6 months of therapy.
Estonian: Anküloseeriva spondüliidiga patsientidel, kes said etanertsepti, oli kliiniline vastus ilmne esimese visiidi ajal (2 nädala möödumisel) ning säilis 6-kuulise ravi lõpuni.
English: In controlled clinical trials of etanercept across all indications, the frequency (incidence proportion) of interstitial lung disease in patients receiving etanercept without concomitant methotrexate was 0.06% (frequency rare).
Estonian: Etanertsepti kontrollitud kliinilistes uuringutes oli interstitsiaalse kopsuhaiguse esinemissagedus (esinemise osakaal) etanertsepti saavatel patsientidel ilma kaasneva metotreksaadita kõigil näidustustel 0,06% (sagedus: harv).
English: Erelzi 50 mg solution for injection in pre-filled syringe EU/1/17/1195/005
Estonian: Erelzi 50 mg süstelahus süstlis EU/1/17/1195/005
English: Holding your pen: • Hold the pen at 90 degrees to the cleaned injection site.
Estonian: • Hoidke pen-süstlit süstekohas 90-kraadise nurga all.
English: In a group of 2,711 plaque psoriasis patients treated with etanercept in double-blind and open-label studies of up to 2.5 years, 30 malignancies and 43 non-melanoma skin cancers were reported.
Estonian: 30 pahaloomulise kasvaja ja 43 mittemelanoom-nahavähi juhust teatati kuni 2,5 aastat kestnud topeltpimedates ja avatud uuringutes 2711 naastulise psoriaasiga patsiendil, keda raviti etanertseptiga.
English: Keep the pre-filled SensoReady pens in the outer carton in order to protect from light.
Estonian: Hoida SensoReady pen-süstlid välispakendis valguse eest kaitstult.
English: Your Erelzi SensoReady pen:
Estonian: Teie Erelzi SensoReady pen-süstel:
English: Within the system organ classes, adverse reactions are listed under headings of frequency (number of patients expected to experience the reaction), using the following categories: very common (≥ 1/10);
Estonian: nimetatud organsüsteemi klassis, kasutades järgnevaid kategooriaid: väga sage (≥ 1/10); sage (≥ 1/100
English: There have been reports of worsening of hepatitis C in patients receiving etanercept.
Estonian: Etanertsepti saavatel patsientidel on esinenud C-hepatiidi ägenemist.
English: ASAS partial remission
Estonian: ASAS-i osaline remissioon
English: 4 pre-filled syringes with a needle guard.
Estonian: 4 süstlit nõelakaitsmega.
English: There have been post-marketing reports of worsening of CHF, with and without identifiable precipitating factors, in patients taking etanercept.
Estonian: Turuletulekujärgselt on teatatud etanertsepti võtvate patsientide südame paispuudulikkuse ägenemisest koos või ilma seda esilekutsuvate faktoritega.
English: 4 pre-filled SensoReady pens
Estonian: 4 SensoReady pen-süstlit
English: Do not use the pen if the expiry date has passed.
Estonian: Ärge kasutage pen-süstlit pärast kõlblikkusaja möödumist.
English: Combining the results of controlled clinical trials, more cases of NMSC were observed in patients receiving etanercept compared with control patients, particularly in patients with psoriasis.
Estonian: Kontrolliga kliiniliste uuringute tulemuste kokkuvõttes esines etanertsepti kasutanud patsientidel, eelkõige psoriaasiga patsientidel, rohkem mittemelanoomset nahavähki kui kontrollrühma kuulunud patsientidel puhul.
English: Your Erelzi pre-filled syringe with needle guard and add-on finger flange
Estonian: Erelzi süstel süstlakaitsme ja lisatud sõrmeäärikuga
English: From the start of part 2, the median time to flare was ≥ 116 days for patients who received etanercept and 28 days for patients who received placebo.
Estonian: Etanertseptiga ravitud patsientide grupis ägenes haigus mediaanselt ≥ 116 päeva möödudes 2. osa algusest; platseeboga ravitutel mediaanselt 28 päeva möödudes.
English: Non-melanoma skin cancers* (see section 4.4)
Estonian: Mittemelanoomsed nahavähid* (vt lõik 4.4)
English: Storage of the Erelzi pre-filled syringe
Estonian: Erelzi süstli säilitamine
English: Comprehensive instructions for administration are given in the package leaflet, section 7, "Instructions for use of the Erelzi SensoReady pen".
Estonian: Üksikasjalikud manustamisjuhised on toodud pakendi infolehel punktis 7 “Erelzi SensoReady pen-süstli kasutusjuhend”.
English: Erelzi 50 mg solution for injection in pre-filled pen EU/1/17/1195/009
Estonian: Erelzi 50 mg süstelahus pen-süstlis EU/1/17/1195/009
English: If any of the following happen, do not inject more Erelzi.
Estonian: Kui täheldate endal ükskõik millist järgnevatest kõrvaltoimetest, lõpetage kohe Erelzi süstimine.
English: 25 mg BIW
Estonian: Etanertsept 25 mg
English: An educational program is developed in order to assist in training and educating HCPs for proper use of Erelzi:
Estonian: Tervishoiutöötajate koolitamiseks Erelzi õige kasutamise alal on välja töötatud koolitusprogramm.
English: Doses of 25 mg of etanercept (based on dose-finding studies in patients with rheumatoid arthritis) or placebo were administered subcutaneously twice a week for 6 months in 138 patients.
Estonian: 138 patsiendile manustati 6 kuu vältel 2 korda nädalas subkutaanselt 25 mg etanertsepti (võttes aluseks annuse määramise uuringu reumotoidartriidiga patsientidel) või platseebot.
English: EU/1/17/1195/005 1 pre-filled syringe EU/1/17/1195/006 2 pre-filled syringes EU/1/17/1195/007 4 pre-filled syringes
Estonian: EU/1/17/1195/005 1 süstel EU/1/17/1195/006 2 süstlit EU/1/17/1195/007 4 süstlit
English: The efficacy of etanercept versus other systemic therapies in patients with moderate to severe psoriasis (responsive to other systemic therapies) has not been evaluated in studies directly comparing etanercept with other systemic therapies.
Estonian: Etanertsepti efektiivsust ei ole hinnatud uuringutes, mis otseselt võrdleksid etanertsepti muude süsteemsete ravidega sellistele ravidele alluva keskmise raskusega kuni raske psoriaasiga patsientidel.
English: Antibodies to etanercept have been detected in the sera of some subjects treated with etanercept.
Estonian: Mõne etanertseptiga ravitud patsiendi seerumist on leitud etanertseptivastaseid antikehi.
English: Instructions for use of the Erelzi pre-filled syringe Read ALL the way through these instructions before injecting.
Estonian: Erelzi SensoReady pen-süstli kasutusjuhend Enne süstimist lugege läbi KOGU kasutusjuhend.
English: EU/1/17/1195/001 1 pre-filled syringe EU/1/17/1195/002 2 pre-filled syringes EU/1/17/1195/003 4 pre-filled syringes
Estonian: EU/1/17/1195/001 1 süstel EU/1/17/1195/002 2 süstlit EU/1/17/1195/003 4 süstlit
English: Choose your injection site:
Estonian: Valige süstekoht:
English: Among patients with plaque psoriasis who received etanercept, significant responses relative to placebo were apparent at the time of the first visit (2 weeks) and were maintained through 24 weeks of therapy.
Estonian: Naastulise psoriaasiga patsientidel, kes said etanertsepti, oli esimese visiidi ajaks (2 nädalat) tekkinud oluline ravivastus võrrelduna platseeboga ja püsis 24-nädalase ravi lõpuni.
English: There have been reports of IBD and uveitis in JIA patients being treated with etanercept (see section 4.8).
Estonian: Juveniilse idiopaatilise artriidiga patsientidel, keda raviti etanertseptiga, esines põletikulist soolehaigust ja uveiiti (vt lõik 4.8).
English: Incorrect
Estonian: Õige Vale
English: Cases of active tuberculosis, including miliary tuberculosis and tuberculosis with extra-pulmonary location, have been reported in patients treated with etanercept.
Estonian: Etanertseptiga ravitud patsientidel on esinenud aktiivset tuberkuloosi, sealhulgas miliaarset või kopsuvälist tuberkuloosi.
English: Rare cases of pancytopenia and very rare cases of aplastic anaemia, some with fatal outcome, have been reported in patients treated with etanercept.
Estonian: Etanertseptiga ravitud patsientidel on harva tekkinud pantsütopeenia ja väga harva aplastiline aneemia, mis mõnikord on lõppenud letaalselt.
English: Instructions for use and handling of the Erelzi pre-filled syringe Before injection, Erelzi single-use pre-filled syringe should be allowed to reach room temperature (approximately 15 to 30 minutes).
Estonian: Enne süstimist tuleb lasta Erelzi ühekordsel süstlil saavutada toatemperatuur (umbes 15 kuni 30 minutit).
English: Each pre-filled pen contains 50 mg etanercept.
Estonian: Iga pen-süstel sisaldab 50 mg etanertsepti.
English: Erelzi 25 mg solution for injection in pre-filled syringe.
Estonian: Erelzi 25 mg süstelahus süstlis.
English: Antibodies to etanercept
Estonian: Etanertseptivastased antikehad
English: Adult patients with non-radiographic axial spondyloarthritis
Estonian: Radiograafilise leiuta aksiaalse spondüloartriidiga täiskasvanud patsiendid
English: C.
Estonian: ϕ
English: How to store Erelzi
Estonian: Kuidas Erelzit säilitada
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON OF UNIT PACK - 50 MG PRE-FILLED PEN
Estonian: VÄLISPAKENDIL PEAVAD OLEMA JÄRGMISED ANDMED ÜKSIKPAKENDI KARP - 50 MG PEN-SÜSTEL